search
Back to results

Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial (PACE SETTER)

Primary Purpose

Myocardial Infarction, Coronary Artery Bypass, Percutaneous Coronary Intervention

Status
Not yet recruiting
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
RPE (usual care)
GXT+THHR (intervention)
Sponsored by
Baystate Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Myocardial Infarction

Eligibility Criteria

60 Years - 101 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patients who are eligible for cardiac rehabilitation by having had a cardiac event such as a myocardial infarction (heart attack), heart failure, percutaneous coronary intervention or angioplasty with stent, coronary artery bypass graft, or heart valve surgery in the past 6 months. Lives in, or plans to reside in, the Springfield, MA, or greater Detroit, MI, area for the next year. Recruited from a Phase 2 Cardiac Rehabilitation Center at either Baystate Medical Center or Henry Ford Health System. Age β‰₯ 60 years Agrees to attend at least 18 sessions of cardiac rehabilitation after randomization Agrees to attend cardiac rehabilitation at least twice a week Exclusion Criteria: These include conditions that alter the physiology and monitoring of resting and exercise heart rate. These also include conditions that might limit an individual's ability to exercise. Permanent atrial fibrillation Heart transplant Left-ventricular assist devices Stable angina High-risk un-revascularized coronary artery disease Symptomatic peripheral artery disease Aortic and/or mitral stenosis Any condition where exercise testing or training might be unsafe or limited

Sites / Locations

  • Baystate Medical Center
  • Henry Ford Health System

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

RPE (usual care)

GXT+ THHR (intervention)

Arm Description

Participants randomized to usual care (RPE) will not complete a GXT. They will instead be scheduled for an approximately 5-minute educational session (i.e., time/attention-matched control condition) where they will receive information about heart-healthy nutrition. This is standard care at both sites. Patients in the control group will follow standard exercise prescription protocols in CR. This will include a baseline exercise assessment on exercise equipment in the gym (e.g., treadmill, elliptical, rower, NuStep, and/or stationary bicycle) as appropriate. Based on exercise levels achieved on the first day, patients will be given exercise recommendations for their 2nd session of CR and so forth. Participants will be asked to exercise at a moderate intensity RPE level at both sites. As the patients progress in CR, patients will increase their time, intensity, and mode of exercise guided by RPE and clinical assessment.

Patients assigned to the intervention group will complete a GXT approximately one week later and ideally prior to the 4th cardiac rehabilitation session. Resting and peak heart rate from the GXT will be recorded and used to calculate a target heart rate range (THRR) using the Karvonen formula (60-85% Heart rate reserve). After the test, they will receive psychoeducational feedback (PF) about their test results and exercise performance. After the PF, we will discuss the THRR and how it will be used to guide exercise intensity in CR. Patients in the intervention group will use their THHR to adjust their exercise intensity. For the first 6 cardiac rehabilitation sessions, patients will receive feedback about heart rate from the PolarHR monitor, research staff and CR staff when available. The goal is for patients to exercise in THRR for the majority of each exercise session.

Outcomes

Primary Outcome Measures

Change in Functional Fitness
Change in functional fitness as measured by 6 minute walk from baseline to cardiac rehabilitation (CR) completion.

Secondary Outcome Measures

Training exercise workload
Change in metabolic equivalents of task (METs)-an objective measure of a training exercise workload as changes in scores over time and between groups.
Short Physical Performance Battery
Change in Short Physical Performance Battery from baseline to final CR session
Change in functional fitness at 6 months
Change in functional fitness as measured by 6-minute walk from end of CR to 6 months later.
Change in physical performance at 6 months
Short Physical Performance Battery from end of CR to 6 months later.

Full Information

First Posted
June 22, 2023
Last Updated
June 22, 2023
Sponsor
Baystate Medical Center
Collaborators
Henry Ford Hospital, University of Pennsylvania, Rutgers, The State University of New Jersey, Springfield College
search

1. Study Identification

Unique Protocol Identification Number
NCT05925634
Brief Title
Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial
Acronym
PACE SETTER
Official Title
Improving Outcomes From Cardiac Rehabilitation Among Older Adults Through Exercise Testing and Individualized Exercise Intensity Prescriptions
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 2023 (Anticipated)
Primary Completion Date
February 2026 (Anticipated)
Study Completion Date
June 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Baystate Medical Center
Collaborators
Henry Ford Hospital, University of Pennsylvania, Rutgers, The State University of New Jersey, Springfield College

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The goal of this clinical trial is to compare two types of exercise prescriptions in cardiac rehabilitation eligible older adults (60 years or older) with heart disease. The investigators found in a single site pilot trial (insert NCTxxx) that one exercise prescription was better and are now repeating this study in a larger population at two sites (Baystate Medical Center, Springfield MA and Henry Ford Health System, Detroit MI). The main questions the investigators aim to answer are: Compare two different exercise prescriptions in cardiac rehabilitation on exercise outcomes Graded exercise test +Target heart rate range prescription [GXT-THRR] Rating of perceived exertion (RPE) What is the role of psychological feedback on fitness outcomes during cardiac rehabilitation and physical activity outside of cardiac rehabilitation. What are the long-term clinical outcomes between the two exercise prescriptions Participants will be asked to: Complete surveys about physical activity, exercise anxiety, exercise efficacy, and fears about exercising Perform fitness measures (6-minute walk test, balance tests, stand to sit tests, a 400 meter walk, and handgrip strength) Attend at least 18 sessions of cardiac rehabilitation after they are randomized to their exercise prescription group Wear a heart rate monitor and a physical activity monitor per study protocol Participants will be randomized (flip of a coin) to either receive a graded exercise test and psychoeducational feedback or lifestyle education (nutrition for cardiac). The graded exercise test will be used to create a personalized exercise prescription with the target heart rate range calculated from the test and the lifestyle education group will use their ratings of perceived exertion for their exercise prescription.
Detailed Description
This study aims to conduct a practical two-arm, parallel-group, open-label, efficacy randomized trial comparing Graded Exercise Testing+ Target Heart Rate Range (GXT-THRR) vs. Usual Care (UC) on changes in fitness (as measured by 6MWT, exercise training METs, handgrip strength and Short Physical Performance Battery [SPPB]) and PA behavior among 320 patients enrolled in CR. The investigators will recruit older adults (age β‰₯ 60 years) attending outpatient CR from two complementary but different CR centers. The investigators will compare changes in fear and self-efficacy between these two groups and measure long-term clinical outcomes. The investigators have designed the study to be as generalizable as possible, so most CR programs can immediately apply the results in clinical practice. Eligible patients who are willing to participate will complete written informed consent. Baseline demographics, comorbidities, and prescribed medications and doses (including beta-blockers) will be collected. Patients will then undergo a baseline assessment. This will include a 6MWT and SPPB using standard guideline procedures. During this time period, patients will also be fitted with an accelerometer to wear for 7 days (Actigraph, CenterPoint, Pensacola, FL) to assess time spent in moderate to vigorous PA (MVPA). The investigators have significant experience assessing PA, 6MWT, and SPPB, and anticipate few issues in making these measurements. Patients will also complete the following psychological assessments: Multidimensional Self-Efficacy for Exercise Scale. Self- efficacy is a robust predictor of exercise and PA behavior and may be influenced by exercise prescription method (GXT-THRR or UC). This validated tool will assess three dimensions of self-efficacy: task efficacy (confidence in performing the elemental aspects of exercise), coping efficacy (confidence in exercising under challenging circumstances), and scheduling efficacy (confidence in being able to schedule regular exercise into one's lifestyle). Exercise Sensitivity Questionnaire (ESQ). The ESQ is an 18-item self-report measure developed by Dr. Farris that conceptualizes exercise anxiety as worry and fear about the physical sensations of exercise. The ESQ has two dimensions: (1) anxiety about cardiopulmonary sensations during exercise (i.e., blurry vision, chest pain/tightness, difficulty breathing) and (2) anxiety about pain/weakness sensations during exercise (i.e., joint/back/body pain, aches, soreness). Exercise Perception Questionnaire. This survey uses relevant subscales of the Intrinsic Motivation Inventory and will assess patient interest/enjoyment, as well as perceived choice, competence, pressure/tension, and effort. Preference for and Tolerance of Exercise Intensity Questionnaire (PRETIE-Q). This validated tool reflects a patient's general attitude towards and tolerance for higher-intensity exercise. We have included this survey as an important baseline measure, which may predict exercise gains and PA patterns. 36 Item Short Form Survey (SF-36). This well-validated general QOL survey has been used extensively in CR and provides a useful measure of a patient's overall physical, emotional, and social QOL. Fried Frailty Phenotype. This assesses physical frailty through five criteria: unintentional weight loss; weakness or poor handgrip strength; self-reported exhaustion; slow walking speed; and low physical activity. International Physical Activity Questionnaire-Elderly. This well-validated survey will assess levels of physical activity (moderate, moderate-vigorous, vigorous) and sedentary activity. During the time between informed consent and randomization, patients will continue to undergo CR using UC to guide intensity. This allows for exercise-related baseline measurements to be taken, including the exercise training METs on the 3rd session of CR, as suggested by AACVPR performance measures. It also allows measurement of baseline resting HR, exercise HR, and exercise RPE. After completing all baseline assessments (including 3 sessions of CR), patients will be randomized (1:1) to either GXT-THRR or UC. Randomization will be stratified based on age, recent cardiac surgery, and site (Baystate vs. Henry Ford.) This will be done because age may have a differential impact on exercise gains; cardiac surgery can limit the available exercise training modalities (i.e., no upper body exercises); and CR site may influence the outcome in unanticipated ways. The investigators will randomize patients through use of the Research Electronic Database Capture (REDCap) software randomization module which allows secure, sequential, and concealed group allocation, as was done in the pilot. REDCap will also be used by both sites to allow uniform data collection, capture, and entry.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myocardial Infarction, Coronary Artery Bypass, Percutaneous Coronary Intervention, Heart Failure, Cardiac Valve Surgery

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Model Description
A practical two-arm, parallel-group, open-label, efficacy randomized trial.
Masking
Outcomes Assessor
Masking Description
The assessment of the 6- minute walk test, handgrip strength, and Short Physical Performance Battery [SPPB]) will be performed by a blinded research team member. The blinding will occur at baseline, end of cardiac rehabilitation, and at 6 months after cardiac rehabilitation.
Allocation
Randomized
Enrollment
320 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
RPE (usual care)
Arm Type
Active Comparator
Arm Description
Participants randomized to usual care (RPE) will not complete a GXT. They will instead be scheduled for an approximately 5-minute educational session (i.e., time/attention-matched control condition) where they will receive information about heart-healthy nutrition. This is standard care at both sites. Patients in the control group will follow standard exercise prescription protocols in CR. This will include a baseline exercise assessment on exercise equipment in the gym (e.g., treadmill, elliptical, rower, NuStep, and/or stationary bicycle) as appropriate. Based on exercise levels achieved on the first day, patients will be given exercise recommendations for their 2nd session of CR and so forth. Participants will be asked to exercise at a moderate intensity RPE level at both sites. As the patients progress in CR, patients will increase their time, intensity, and mode of exercise guided by RPE and clinical assessment.
Arm Title
GXT+ THHR (intervention)
Arm Type
Experimental
Arm Description
Patients assigned to the intervention group will complete a GXT approximately one week later and ideally prior to the 4th cardiac rehabilitation session. Resting and peak heart rate from the GXT will be recorded and used to calculate a target heart rate range (THRR) using the Karvonen formula (60-85% Heart rate reserve). After the test, they will receive psychoeducational feedback (PF) about their test results and exercise performance. After the PF, we will discuss the THRR and how it will be used to guide exercise intensity in CR. Patients in the intervention group will use their THHR to adjust their exercise intensity. For the first 6 cardiac rehabilitation sessions, patients will receive feedback about heart rate from the PolarHR monitor, research staff and CR staff when available. The goal is for patients to exercise in THRR for the majority of each exercise session.
Intervention Type
Behavioral
Intervention Name(s)
RPE (usual care)
Other Intervention Name(s)
Relative Perceived Exertion (RPE) Exercise Group
Intervention Description
Patients in the active comparator group will follow standard exercise prescription protocols in cardiac rehabilitation.
Intervention Type
Behavioral
Intervention Name(s)
GXT+THHR (intervention)
Other Intervention Name(s)
Experimental: Graded Exercise Test (GXT) + Target Heart Rate Range (THHR)
Intervention Description
Patients in the personalized care group will perform a graded exercise test and the peak heart rate from the test will allow the researcher to calculate a target heart rate range (THRR). Then, the patients will receive psychoeducational feedback (PF) about their test results and exercise performance. After PF, their THRR will be reviewed and how it will be used to guide exercise intensity in CR will be discussed.
Primary Outcome Measure Information:
Title
Change in Functional Fitness
Description
Change in functional fitness as measured by 6 minute walk from baseline to cardiac rehabilitation (CR) completion.
Time Frame
Baseline to final CR session
Secondary Outcome Measure Information:
Title
Training exercise workload
Description
Change in metabolic equivalents of task (METs)-an objective measure of a training exercise workload as changes in scores over time and between groups.
Time Frame
3rd CR session to final CR session
Title
Short Physical Performance Battery
Description
Change in Short Physical Performance Battery from baseline to final CR session
Time Frame
Baseline to final CR session
Title
Change in functional fitness at 6 months
Description
Change in functional fitness as measured by 6-minute walk from end of CR to 6 months later.
Time Frame
From end of final CR session to 6 months later.
Title
Change in physical performance at 6 months
Description
Short Physical Performance Battery from end of CR to 6 months later.
Time Frame
From end of final CR session to 6 months later.
Other Pre-specified Outcome Measures:
Title
Self-efficacy (task efficacy)
Description
Acute change in self-efficacy (task efficacy) measured before and after the intervention (graded exercise test (GXT) vs. time matched control) will be assessed via the Multidimensional Self-Efficacy for Exercise Scale as changes in scores over time and between groups.
Time Frame
Pre-Post GXT
Title
Fear of Exercise
Description
Acute effects of GXT vs. time matched control on fear will be measured via the Exercise Sensitivity Questionnaire as changes in scores over time and between groups.
Time Frame
Pre-Post GXT
Title
Reassurance
Description
Acute effects of GXT on reassurance will be measured via the Reassurance Scale as change scores over time and between groups.
Time Frame
Pre-Post GXT
Title
Exercise Anxiety
Description
Change in exercise anxiety from baseline to final CR session over time and between groups will be measured via the Exercise Sensitivity Questionnaire.
Time Frame
Baseline to final CR session
Title
Exercise Self-Efficacy
Description
Change in exercise self-efficacy from baseline to final CR session over time and between groups will be measured via the Preference for and Tolerance of Exercise Intensity Questionnaire.
Time Frame
Baseline to final CR session
Title
Task Efficacy
Description
Change in task self-efficacy from baseline to final CR session over time and between groups will be measured via the Multidimensional Self-Efficacy for Exercise Scale.
Time Frame
Baseline to final CR session
Title
Change in Quality of Life
Description
Change in Quality of Life measured by the SF-36 from baseline to the end of CR
Time Frame
Baseline to final CR session
Title
Change in 7-day % time in Moderate to Vigorous Physical Activity
Description
Total minutes/day in moderate to vigorous physical activity that is structured exercise behavior measured with an accelerometer.
Time Frame
Baseline to final CR session
Title
Self-reported moderate to vigorous physical activity (MVPA) over the past 7 days
Description
Using the International physical activity questionnaire (IPAQ) to measure self-reported moderate to vigorous physical activity (MVPA) over the past 7 days
Time Frame
Baseline to CR end, and at 3 and 6 months post CR
Title
Major adverse cardiac event (death, myocardial infarction, stroke)
Description
A cardiovascular event including myocardial infarction or stroke, or death via reporting of events in the follow-up surveys via REDCap links or phone calls.
Time Frame
At end of CR up to 2 years follow-up
Title
Admission to the hospital (full admission or observation status) with apparent life-threatening illness
Description
Any full admission or observation status admission to a hospital with apparent life-threatening illness via reporting of events in the follow-up surveys via REDCap links or phone calls.
Time Frame
At end of CR up to 2 years follow-up
Title
Clinically indicated ischemic evaluation (exercise stress test, nuclear stress test, exercise echo, cardiac catheterization)
Description
A clinically indicated ischemic event during exercise stress test, nuclear stress test, exercise echo or cardiac catheterization via reporting of events in the follow-up surveys via REDCap links or phone calls.
Time Frame
At end of CR up to 2 years follow-up
Title
Number of sessions of CR completed (maximum of 36) within 6 months of enrollment.
Description
After enrollment to cardiac rehabilitation (CR) the number of sessions completed within 6 months, with a maximum of 36 possible via the case report forms completed per participant.
Time Frame
Start to end of CR

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Maximum Age & Unit of Time
101 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients who are eligible for cardiac rehabilitation by having had a cardiac event such as a myocardial infarction (heart attack), heart failure, percutaneous coronary intervention or angioplasty with stent, coronary artery bypass graft, or heart valve surgery in the past 6 months. Lives in, or plans to reside in, the Springfield, MA, or greater Detroit, MI, area for the next year. Recruited from a Phase 2 Cardiac Rehabilitation Center at either Baystate Medical Center or Henry Ford Health System. Age β‰₯ 60 years Agrees to attend at least 18 sessions of cardiac rehabilitation after randomization Agrees to attend cardiac rehabilitation at least twice a week Exclusion Criteria: These include conditions that alter the physiology and monitoring of resting and exercise heart rate. These also include conditions that might limit an individual's ability to exercise. Permanent atrial fibrillation Heart transplant Left-ventricular assist devices Stable angina High-risk un-revascularized coronary artery disease Symptomatic peripheral artery disease Aortic and/or mitral stenosis Any condition where exercise testing or training might be unsafe or limited
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Quinn R Pack, MD
Phone
413-794-5856
Email
quinn.pack@baystatehealth.org
First Name & Middle Initial & Last Name or Official Title & Degree
Karen L Riska, PhD
Phone
413-794-0303
Email
karen.riska@baystatehealth.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Quinn R Pack, MD
Organizational Affiliation
Baystate Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Baystate Medical Center
City
Springfield
State/Province
Massachusetts
ZIP/Postal Code
01199
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Quinn Pack, MD
Email
quinn.pack@baystatehealth.org
First Name & Middle Initial & Last Name & Degree
Karen Riska, PhD
Email
karen.riska@baystatehealth.org
Facility Name
Henry Ford Health System
City
Detroit
State/Province
Michigan
ZIP/Postal Code
48202
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Clinton Brawner, PhD
Email
cbrawne1@hfhs.org
First Name & Middle Initial & Last Name & Degree
Wanda Qualters
Email
wqualte1@hfhs.org

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial

We'll reach out to this number within 24 hrs